(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
Hepatitis
People ages 18-65 who have hepatitis may qualify to participate in a clinical research study of a 9-week evaluation of hepatitis C patients using the combination of ribavirin and peg-interferon alfa-2a. Research site located in Orlando, Fla.
More Information
Please see http://www.centerwatch.com/patient/studies/cat79.html.
-----
High Cholesterol (Hyperlipidemia)
A study to evaluate the efficacy and safety of rosuvastatin and atorvastatin in the treatment of hypercholesterolemia in Hispanic subjects. Hispanic participants age 18 and older with high cholesterol may be eligible. Research site located in Golden, Colo.
More Information
Please see http://www.centerwatch.com/patient/studies/cat170.html.
-----
Menopause
Understanding the role that hot flashes and sleep disruption play in the effect of estrogen replacement therapy on mood in perimenopausal women. Perimenopausal woman aged 40-58 with frequent hot flashes, sleeplessness, and mood swings may be eligible. Research site located in Boston, Mass.
More Information
Please see http://www.centerwatch.com/patient/studies/cat181.html.
-----
Copyright 2003 CenterWatch. All rights reserved.